Search research articles
Contact Us
Filters
Showing results (151-160 of 174) with videos related to
Page
of 18
Sort By:
Molecular Pharmacology
|
September 20, 2007
Repression of T-cell function by thionamides is mediated by inhibition of the activator protein-1/nuclear factor of activated T-cells pathway and is associated with a common structure
Matjaz Humar, Hannah Dohrmann, Philipp Stein, et al.
Blood
|
March 10, 2018
Epigenetic regulation of NFE2 overexpression in myeloproliferative neoplasms
Jan C Peeken, Jonas S Jutzi, Julius Wehrle, et al.
Annals of Hematology
|
October 4, 2023
Real-world analysis of ruxolitinib in myelofibrosis: interim results focusing on patients who were naïve to JAK inhibitor therapy treated within the JAKoMo non-interventional, phase IV trial
Steffen Koschmieder, Susanne Isfort, Clemens Schulte, et al.
European Journal of Haematology
|
July 7, 2025
Final Results From a Large, Non-Interventional, Phase 4 Study of Ruxolitinib for the Treatment of Myelofibrosis in Clinical Routine
Steffen Koschmieder, Susanne Isfort, Clemens Schulte, et al.
Leukemia
|
August 4, 2012
Gab2 signaling in chronic myeloid leukemia cells confers resistance to multiple Bcr-Abl inhibitors
F U Wöhrle, S Halbach, K Aumann, et al.
Leukemia
|
February 9, 2016
Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both
S Koschmieder, T I Mughal, H C Hasselbalch, et al.
Leukemia Research
|
September 24, 2020
Prevalence and characteristics of myeloproliferative neoplasms with concomitant monoclonal gammopathy
Nora Rebeka Javorniczky, Julius Wehrle, Gabriele Ihorst, et al.
Experimental Hematology
|
March 20, 2026
From Image to Insight: Optimized Multiplex Staining Panel for FFPE Mouse Bone Marrow Enables Spatial Profiling of the Hematopoietic Niche
Franziska Zell, Katharina Gellrich, Albert Gründer, et al.
British Journal of Haematology
|
July 6, 2018
Gene mutations and clonal architecture in myelodysplastic syndromes and changes upon progression to acute myeloid leukaemia and under treatment
Juliane M Stosch, Anezka Heumüller, Christoph Niemöller, et al.
The Journal of Experimental Medicine
|
April 17, 2013
MPN patients harbor recurrent truncating mutations in transcription factor NF-E2
Jonas S Jutzi, Ruzhica Bogeska, Gorica Nikoloski, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 174) with videos related to
Sort By:
Page
of 18
Molecular Pharmacology
|
September 20, 2007
Repression of T-cell function by thionamides is mediated by inhibition of the activator protein-1/nuclear factor of activated T-cells pathway and is associated with a common structure
Matjaz Humar, Hannah Dohrmann, Philipp Stein, et al.
Blood
|
March 10, 2018
Epigenetic regulation of NFE2 overexpression in myeloproliferative neoplasms
Jan C Peeken, Jonas S Jutzi, Julius Wehrle, et al.
Annals of Hematology
|
October 4, 2023
Real-world analysis of ruxolitinib in myelofibrosis: interim results focusing on patients who were naïve to JAK inhibitor therapy treated within the JAKoMo non-interventional, phase IV trial
Steffen Koschmieder, Susanne Isfort, Clemens Schulte, et al.
European Journal of Haematology
|
July 7, 2025
Final Results From a Large, Non-Interventional, Phase 4 Study of Ruxolitinib for the Treatment of Myelofibrosis in Clinical Routine
Steffen Koschmieder, Susanne Isfort, Clemens Schulte, et al.
Leukemia
|
August 4, 2012
Gab2 signaling in chronic myeloid leukemia cells confers resistance to multiple Bcr-Abl inhibitors
F U Wöhrle, S Halbach, K Aumann, et al.
Leukemia
|
February 9, 2016
Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both
S Koschmieder, T I Mughal, H C Hasselbalch, et al.
Leukemia Research
|
September 24, 2020
Prevalence and characteristics of myeloproliferative neoplasms with concomitant monoclonal gammopathy
Nora Rebeka Javorniczky, Julius Wehrle, Gabriele Ihorst, et al.
Experimental Hematology
|
March 20, 2026
From Image to Insight: Optimized Multiplex Staining Panel for FFPE Mouse Bone Marrow Enables Spatial Profiling of the Hematopoietic Niche
Franziska Zell, Katharina Gellrich, Albert Gründer, et al.
British Journal of Haematology
|
July 6, 2018
Gene mutations and clonal architecture in myelodysplastic syndromes and changes upon progression to acute myeloid leukaemia and under treatment
Juliane M Stosch, Anezka Heumüller, Christoph Niemöller, et al.
The Journal of Experimental Medicine
|
April 17, 2013
MPN patients harbor recurrent truncating mutations in transcription factor NF-E2
Jonas S Jutzi, Ruzhica Bogeska, Gorica Nikoloski, et al.
Page
of 18